![5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone](https://static.cymitquimica.com/products/3D/img/XJB57393.png "Click to enlarge")
5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone
CAS: 872573-93-8
Ref. 3D-XJB57393
| 5mg | Discontinued | ||
| 10mg | Discontinued | ||
| 25mg | Discontinued | ||
| 50mg | Discontinued | ||
| 100mg | Discontinued |
Product Information
Name:
5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone
Synonyms:
- Ro-3306
- (5Z)-5-(quinolin-6-ylmethylidene)-2-(thiophen-2-ylmethylamino)-1,3-thiazol-4-one
- 5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone
- (Z)-5-(quinolin-6-ylmethylene)-2-(thiophen-2-ylmethylamino)thiazol-4(5H)-one
- 2-[[(Thiophen-2-yl)methyl]amino]-5-[1-(quinolin-6-yl)meth-(Z)-ylidene]thiazol-4-one
- (5Z)-5-Quinolin-6-ylmethylene-2-[(thiophen-2-ylmethyl)-amino]-thiazol-4-one
Description:
Quizartinib is a targeted inhibitor of the protein kinase A-Raf signaling pathway and is used for the treatment of certain types of cancer. Quizartinib inhibits the polymerase chain reaction, which can lead to cell death. It also has inhibitory properties on some cancer cells by targeting her2+ breast cancer cells and inhibiting tumor growth in vivo models. Quizartinib has been shown to be effective against autoimmune diseases such as lupus erythematosus, rheumatoid arthritis, and psoriasis. This drug also exhibits pluripotency markers that are similar to those found in embryonic stem cells.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:
Chemical properties
Molecular weight:
351.45 g/mol
Formula:
C18H13N3OS2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
